Skip to content
healthcare.dev
Get a free key

Hizentra

NDC 44206-458, HUMAN IMMUNOGLOBULIN G, liquid, from CSL Behring AG.

Product NDC
44206-458
Status
Listed
Labeler
CSL Behring AG
Dosage form
LIQUID
Route
SUBCUTANEOUS
Product type
PLASMA DERIVATIVE
Marketing category
BLA
Application
BLA125350
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/44206-458 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • HUMAN IMMUNOGLOBULIN G.2 g/mL

Pharmacologic classes

Antigen Neutralization [MoA]; Human Immunoglobulin G [EPC]; Immunoglobulins [CS]; Passively Acquired Immunity [PE]

Package NDCNDC-11Package
44206-458-24442060458241 SYRINGE in 1 CARTON (44206-458-24) / 20 mL in 1 SYRINGE (44206-458-96)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=44206-458

Use it

Look up 44206-458 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/44206-458 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 44206-458. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.